These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2119831)

  • 21. Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton.
    Peerschke EI
    Blood; 1991 Feb; 77(3):508-14. PubMed ID: 1899346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies against porcine platelet membrane glycoproteins Ib and IIb/IIIa.
    Takami H; Nichols WL; Kaese SE; Miller RS; Katzmann JA; Bowie EJ
    Blood; 1988 Nov; 72(5):1740-7. PubMed ID: 3140912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation.
    Kovacsovics TJ; Hartwig JH
    Blood; 1996 Jan; 87(2):618-29. PubMed ID: 8555484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib.
    George JN; Torres MM
    Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
    Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
    Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
    Naimushin YA; Mazurov AV
    Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of various extraction solutions and thrombin activation on the composition of the platelet cytoskeleton.
    Rosenberg S; Lawrence J; Stracher A
    Cell Motil; 1982; 2(4):317-32. PubMed ID: 6817921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib.
    Peng M; Lu W; Kirby EP
    Biochemistry; 1991 Dec; 30(49):11529-36. PubMed ID: 1747371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.
    Adelman B; Michelson AD; Loscalzo J; Greenberg J; Handin RI
    Blood; 1985 Jan; 65(1):32-40. PubMed ID: 3155489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of a recombinant glycoprotein Ib alpha polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen.
    Cruz MA; Petersen E; Turci SM; Handin RI
    J Biol Chem; 1992 Jan; 267(2):1303-9. PubMed ID: 1730650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
    Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of toluene on platelet membrane glycoprotein Ib and actin-binding protein.
    Aakhus AM; Smith-Kielland A; Ripel A; Solum NO
    Biochem Pharmacol; 1991 Jul; 42(4):805-11. PubMed ID: 1867638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of pp60src with Triton X-100-insoluble residue in human blood platelets requires platelet aggregation and actin polymerization.
    Oda A; Druker BJ; Smith M; Salzman EW
    J Biol Chem; 1992 Oct; 267(28):20075-81. PubMed ID: 1400325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S
    Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response of human and bovine platelets to bovine von Willebrand factor and vascular subendothelium.
    Rao GH; Escolar G; White JR; Weiss DJ; Burris S; Ordinas A; White JG
    Platelets; 2001 May; 12(3):150-5. PubMed ID: 11304416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function.
    Natarajan P; May JA; Sanderson HM; Zabe M; Spangenberg P; Heptinstall S
    Platelets; 2000 Dec; 11(8):467-76. PubMed ID: 11177446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.